Updated efficacy of lenvatinib (LEN) + pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study Meeting Abstract
| Authors: | Porta, C. G.; Eto, M.; Motzer, R. J.; De Giorgi, U. F. F.; Buchler, T.; Basappa, N. S.; Vidal, M. J. M.; Tjulandin, S.; Park, S. H.; Melichar, B.; Hutson, T. E.; Alemany, C.; McGregor, B.; He, C. S.; Perini, R.; Mody, K.; McKenzie, J.; Choueiri, T. K. |
| Abstract Title: | Updated efficacy of lenvatinib (LEN) + pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S1205 |
| End Page: | S1206 |
| Language: | English |
| ACCESSION: | WOS:000866211602001 |
| DOI: | 10.1016/j.annonc.2022.07.1552 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1449MO -- Source: Wos |
